KNSA Chart
- 52-Week Range: $7.76 - $16.23
- Market Capitalization: $566.68M
- Short Percentage: 0%
- Target Price: $23.25
- Shares Outstanding: 34.28M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
KNSA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- 22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco BusinessGlobeNewsWire | May 23rd
- Albireo Presented Data in Cholestatic Liver Diseases at Digestive Disease Week (DDW) 2022GlobeNewsWire | May 23rd
We searched over 50 sources and couldn't find any news or press releases related to Kiniksa Pharmaceuticals Ltd.
Here are some articles we think you might like.
Company Info
Website: https://www.kiniksa.com
Address: Clarendon House, Hamilton, Bermuda, HM 11
Sector: Healthcare
Industry: Biotechnology
Full time employees: 215
Address: Clarendon House, Hamilton, Bermuda, HM 11
Sector: Healthcare
Industry: Biotechnology
Full time employees: 215
$KNSA lets go!!
$KNSA this market love evrry dips let’s see
$KNSA bull trap confirmed
$KNSA Tendie tickets on discount today!!!
$KNSA Buy the dip
$KNSA might see a whole 1% green
$KNSA lmfao
lfg babies
$KNSA Holding
$KNSA Shorts talk the talk but cant walk the walk
$KNSA let’s buy NOW!!!